glp 1 with blue cross blue shield BCBSM pulling back on GLP-1 coverage Alternatives to GLP-1 medication?

It is a legitimate modification that does not reduce long-term effectiveness

Promotes Glycemic Stability- Modulating insulin & glucagon release, significantly reducing appetite & cravings

Then, titrated amounts of WT albumin and QMP, either not exposed or exposed to CPA, were added and detected with an alkaline phosphatase (ALP)-conjugated anti-human albumin antibody

PLoS ONE 18 , e0280483 (2023)

This FDA-approved treatment works by reducing appetite and promoting fat loss, providing you with noticeable results without extensive lifestyle changes

Here we report the preclinical pharmacological evaluation of a single molecule conjugate of tesaglitazar covalently attached to a biochemically optimized non-acylated glucagon-like peptide-1 analogue (GLP-1 Aib2 Glu16 CEX Lys40)